Product Center
Astragalus Extract - Astragaloside IV 5%
Astragaloside I. This product is a saponin compound extracted from the dried roots of Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao, a leguminous plant native to Mongolia, or of Astragalus membranaceus (Fisch.) Bge., a species also known as membranous-fruited astragalus.
Category:
Medicinal and Edible Homology
Men's Health
Standardized Extract
Health Supplement
Keywords:
Service phone:
- Product Description
-
- Commodity name: Astragalus Extract - Astragaloside IV 5%
Astragaloside I. This product is a saponin compound extracted from the dried roots of Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao, a leguminous plant native to Mongolia, or of Astragalus membranaceus (Fisch.) Bge., a species also known as membranous-fruited astragalus.
I. Basic Product Information
Project
Content
Product Name
Astragalus Extract
English name
Astragalus extract
CAS NO.
Source
Leguminous plant Astragalus mongolicus Astragalus membranaceus ( Fisch. ) Bge. var. mongholicus ( Bge. ) Hsiao Astragalus membranaceus Astragalus membranaceus ( Fisch. ) Bge. The dried root.
Active ingredient
Astragaloside I
Product Specifications
5%
Detection method
HPLC
Product characteristics
Brownish-yellow Powder
Solubility
In the water Slightly soluble Heated in methanol or ethanol, it can... dissolve in, on DMSO (Dimethyl sulfoxide) is highly soluble.
II. Product Introduction
1. Source
Astragaloside I This product is Mongolian Astragalus, a plant of the legume family. Astragalus membranaceus ( Fisch. ) Bge. var. mongholicus ( Bge. ) Hsiao Astragalus membranaceus Astragalus membranaceus ( Fisch. ) Bge. the dried root Extracted Saponin compounds 。
2. Core Benefits and Applications
- Clinical applications (as a drug ingredient or as an adjunctive therapy)
Adjuvant therapy for tumors: Used in combination with chemotherapy and radiotherapy to reduce side effects, boost immunity, and improve patients' quality of life. This is currently a widely applied area in clinical practice.
Cardiovascular and cerebrovascular diseases: Used as an adjunctive medication to improve cardiac function in the treatment of chronic heart failure, coronary heart disease, angina pectoris, viral myocarditis, and other conditions.
Immunodeficiency: Used for individuals with weakened immune systems and increased susceptibility to infection due to various causes, such as post-surgery, post-severe illness, or post-radiotherapy and chemotherapy.
Viral Hepatitis and Liver Fibrosis: As an adjunctive therapeutic agent for liver protection and anti-fibrotic treatment.
Chronic kidney disease—particularly diabetic nephropathy—is used to slow disease progression.
( 2 ) Health supplements and functional foods
Since astragaloside IV is the hallmark component of Astragalus, many... “ Boost immunity ” For health supplements marketed as having specific benefits, the quality control standard is the content of astragaloside. Common forms include:Astragalus Extract Capsules / Tablet
Compound health supplement containing Astragalus.
Oral liquids such as Astragalus effervescent tablets and Astragalus extract.
( 3 ) Cosmetics and Skincare Products
Leveraging its antioxidant, anti-inflammatory, and repair-promoting properties, astragaloside IV has been added to some high-end skincare products, which claim to offer: anti-aging and wrinkle reduction. , Soothes sensitive skin and repairs the skin barrier. , Brighten skin tone 。III. Technical Specifications and Testing Standards
Testing items
Testing standards
Test results
Detection method
Specifications
≥5%
5.1%
HPLC
Characteristics
Brownish-yellow Powder
Brownish-yellow Powder
Visual inspection
Smell
Unusual odor
Unusual odor
Sensory evaluation
Granularity
99% passes through an 80-mesh sieve.
99% passes through an 80-mesh sieve.
Sift
Heavy metals
≤10 ppm
<10 ppm
AAS
Lead
≤2 ppm
<2 ppm
AAS
Arsenic
≤2 ppm
<2 ppm
AAS
Moisture
≤5.0%
3.2%
Constant-temperature drying method
Ash content
≤5.0%
2.3%
High-temperature incineration method
Total colony count
≤5000 CFU/g
1000 CFU/g
Plate Count Method
Mold yeast
≤500 CFU/g
100 CFU/g
Plate Count Method
Escherichia coli
Not detectable
Not detectable
Selective medium method
Salmonella
Not detectable
Not detectable
Selective enrichment method
IV. Packaging and Storage
1. Packaging specifications
● Small packaging: Sterile aluminum foil pouch (lined with a double-layer polyethylene bag)
● Large packaging: 25 kg cardboard drum (lined with double-layer polyethylene bags, drum lid sealed);
● Export packaging: Packaging available upon request.
2. Storage conditions
● Storage conditions: Store in a sealed, cool, and dry place (temperature ≤25℃, relative humidity ≤60%), and avoid direct sunlight, high temperatures, and humidity.
● Shelf life: 24 months when stored under appropriate conditions and the package remains unopened.
● Transportation precautions: Handle with care and avoid crushing or damage; during transportation, protect from sunlight and moisture.
Previous page